These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 14631544

  • 1. Hyperviscosity in polycythemia vera and other red cell abnormalities.
    Kwaan HC, Wang J.
    Semin Thromb Hemost; 2003 Oct; 29(5):451-8. PubMed ID: 14631544
    [Abstract] [Full Text] [Related]

  • 2. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ, Berneman Z, Schroyens W, Finazzi G, Budde U, van Vliet HH.
    Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
    [Abstract] [Full Text] [Related]

  • 3. Hemorheologic considerations in the pathogenesis of vascular occlusive events in polycythemia vera.
    Pearson TC.
    Semin Thromb Hemost; 1997 Sep; 23(5):433-9. PubMed ID: 9387202
    [Abstract] [Full Text] [Related]

  • 4. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ, Berneman Z, Schroyens W, Koudstaal PJ, Lindemans J, Neumann HA, van Vliet HH.
    Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
    [Abstract] [Full Text] [Related]

  • 5. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
    Michiels JJ, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W.
    Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
    [Abstract] [Full Text] [Related]

  • 6. Laboratory investigations and prediction of thrombotic risk in polycythemia vera.
    Boneu B.
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):183-5. PubMed ID: 8036139
    [Abstract] [Full Text] [Related]

  • 7. [Polycythemic hyperviscosity syndromes].
    Tura S, Finelli C, Ricci P.
    Ric Clin Lab; 1983 Apr; 13 Suppl 3():105-14. PubMed ID: 6672989
    [Abstract] [Full Text] [Related]

  • 8. Blood viscosity and thrombosis: clinical considerations.
    Smith BD, La Celle PL.
    Prog Hemost Thromb; 1982 Apr; 6():179-201. PubMed ID: 6762612
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of arterial compliance in polycythemia vera patients: short and long-term influence of phlebotomy.
    Nemets A, Isakov I, Huerta M, Barshai Y, Oren S, Lugassy G.
    Isr Med Assoc J; 2006 Dec; 8(12):845-7. PubMed ID: 17214101
    [Abstract] [Full Text] [Related]

  • 10. Arterial stenosis and atherothrombotic events in polycythemia vera and essential thrombocythemia.
    Cucuianu A, Stoia M, Farcaş A, Dima D, Zdrenghea M, Paţiu M, Olinic D, Petrov L.
    Rom J Intern Med; 2006 Dec; 44(4):397-406. PubMed ID: 18386616
    [Abstract] [Full Text] [Related]

  • 11. Increased plasma viscosity in plasma cell dyscrasia and whole blood viscosity in polycythemia vera.
    Shin DW, Gu JY, Kim JS, Jung JS, Shin DY, Koh Y, Kim I, Kim HK.
    Clin Hemorheol Microcirc; 2018 Dec; 70(1):59-67. PubMed ID: 29660912
    [Abstract] [Full Text] [Related]

  • 12. Abnormal adhesion of red blood cells in polycythemia vera: a prothrombotic effect?
    El Nemer W, De Grandis M, Brusson M.
    Thromb Res; 2014 May; 133 Suppl 2():S107-11. PubMed ID: 24862129
    [Abstract] [Full Text] [Related]

  • 13. [Role of erythrocytes in thromboembolism pathology].
    Wautier JL.
    Ann Med Interne (Paris); 1986 May; 137(6):477-9. PubMed ID: 3813282
    [Abstract] [Full Text] [Related]

  • 14. Polycythemia vera: a review.
    Golden C.
    Clin J Oncol Nurs; 2003 May; 7(5):553-6. PubMed ID: 14603552
    [Abstract] [Full Text] [Related]

  • 15. Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: the role of neutrophils.
    Falanga A, Marchetti M, Barbui T, Smith CW.
    Semin Hematol; 2005 Oct; 42(4):239-47. PubMed ID: 16210037
    [Abstract] [Full Text] [Related]

  • 16. Rheological study on vascular occlusion and cellular hyperviscosity syndrome in polycythemia vera.
    Fujioka S.
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):688-95. PubMed ID: 2618545
    [Abstract] [Full Text] [Related]

  • 17. Pathogenesis and management of bleeding in essential thrombocythemia and polycythemia vera.
    Elliott MA, Tefferi A.
    Curr Hematol Rep; 2004 Sep; 3(5):344-51. PubMed ID: 15341701
    [Abstract] [Full Text] [Related]

  • 18. Role of plasma proteins in whole blood viscosity: a brief clinical review.
    Kwaan HC.
    Clin Hemorheol Microcirc; 2010 Sep; 44(3):167-76. PubMed ID: 20364062
    [Abstract] [Full Text] [Related]

  • 19. Target hematologic values in the management of essential thrombocythemia and polycythemia vera.
    Hernández-Boluda JC, Gómez M.
    Eur J Haematol; 2015 Jan; 94(1):4-11. PubMed ID: 24814134
    [Abstract] [Full Text] [Related]

  • 20. Polycythemia vera.
    Stuart BJ, Viera AJ.
    Am Fam Physician; 2004 May 01; 69(9):2139-44. PubMed ID: 15152961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.